XML 57 R46.htm IDEA: XBRL DOCUMENT v3.10.0.1
Segment Information (Tables)
6 Months Ended
Jun. 30, 2018
Segment Reporting [Abstract]  
Schedule of Segment Reportable Segments, by Segment The following tables set forth certain information relating to our segments’ operations.
(amounts in thousands)
North
America
 
Europe
 
Australasia
 
Total Operating
Segments
 
Corporate
and
Unallocated
Costs
 
Total
Consolidated
Three Months Ended June 30, 2018
 
 
 
 
 
 
 
 
 
 
Total net revenues
$
673,508

 
$
318,778

 
$
184,297

 
$
1,176,583

 
$

 
$
1,176,583

Intersegment net revenues
(287
)
 
(82
)
 
(3,717
)
 
(4,086
)
 

 
(4,086
)
Net revenues from external customers
$
673,221

 
$
318,696

 
$
180,580

 
$
1,172,497

 
$

 
$
1,172,497

Impairment and restructuring charges
(565
)
 
457

 
2,410

 
2,302

 
211

 
2,513

Adjusted EBITDA
79,642

 
37,933

 
24,195

 
141,770

 
(6,809
)
 
134,961

Three Months Ended July 1, 2017
 
 
 
 
 
 
 
 
 

Total net revenues
$
552,298

 
$
259,426

 
$
140,693

 
$
952,417

 
$

 
$
952,417

Intersegment net revenues
(561
)
 
(537
)
 
(2,531
)
 
(3,629
)
 

 
(3,629
)
Net revenues from external customers
$
551,737

 
$
258,889

 
$
138,162

 
$
948,788

 
$

 
$
948,788

Impairment and restructuring charges
99

 
451

 

 
550

 
4

 
554

Adjusted EBITDA
79,830

 
37,065

 
17,335

 
134,230

 
(8,903
)
 
125,327

(amounts in thousands)
North
America
 
Europe
 
Australasia
 
Total Operating
Segments
 
Corporate
and
Unallocated
Costs
 
Total
Consolidated
Six Months Ended June 30, 2018
 
 
 
 
 
 
 
 
 
 
Total net revenues
$
1,171,841

 
$
621,247

 
$
332,997

 
$
2,126,085

 
$

 
$
2,126,085

Intersegment net revenues
(679
)
 
(864
)
 
(5,866
)
 
(7,409
)
 

 
(7,409
)
Net revenues from external customers
$
1,171,162

 
$
620,383

 
$
327,131

 
$
2,118,676

 
$

 
$
2,118,676

Impairment and restructuring charges
2,191

 
705

 
3,750

 
6,646

 
(1,159
)
 
5,487

Adjusted EBITDA
126,677

 
71,740

 
40,937

 
239,354

 
(16,561
)
 
222,793

Six Months Ended July 1, 2017
 
 
 
 
 
 
 
 
 
 
Total net revenues
$
1,036,928

 
$
502,094

 
$
265,035

 
$
1,804,057

 
$

 
$
1,804,057

Intersegment net revenues
(1,028
)
 
(883
)
 
(5,505
)
 
(7,416
)
 

 
(7,416
)
Net revenues from external customers
$
1,035,900

 
$
501,211

 
$
259,530

 
$
1,796,641

 
$

 
$
1,796,641

Impairment and restructuring charges
335

 
1,324

 

 
1,659

 
97

 
1,756

Adjusted EBITDA
130,008

 
64,270

 
30,584

 
224,862

 
(18,573
)
 
206,289

Reconciliation of Net Income to Adjusted EBITDA Reconciliations of net income to Adjusted EBITDA are as follows:
 
Three Months Ended
 
Six Months Ended
(amounts in thousands)
June 30,
2018
 
July 1,
2017
 
June 30,
2018
 
July 1,
2017
Net income
$
35,452

 
$
46,778

 
$
75,723

 
$
53,206

Equity earnings of non-consolidated entities

 
(1,073
)
 
(738
)
 
(1,554
)
Income tax expense
23,189

 
17,703

 
19,164

 
19,955

Depreciation and amortization
30,572

 
25,990

 
59,031

 
53,052

Interest expense, net (a)
17,830

 
17,547

 
33,491

 
44,439

Impairment and restructuring charges (b)
2,513

 
577

 
5,487

 
1,757

Gain on previously held shares of equity investment

 

 
(20,767
)
 

Loss (gain) on sale of property and equipment
103

 
(34
)
 
17

 
(77
)
Stock-based compensation expense
6,290

 
5,339

 
8,241

 
10,783

Non-cash foreign exchange transaction/translation (income) loss
(5,814
)
 
2,754

 
(1,933
)
 
7,114

Other non-cash items (c)
12,223

 
(16
)
 
12,223

 
(15
)
Other items (d)
12,494

 
9,754

 
32,779

 
17,341

Costs relating to debt restructuring and debt refinancing (e)
109

 
8

 
75

 
288

Adjusted EBITDA
$
134,961

 
$
125,327

 
$
222,793

 
$
206,289


(a)
Interest expense for the six months ended July 1, 2017 includes $6,097 related to the write-off of a portion of the unamortized debt issuance costs and original issue discount associated with the Term Loan Facility.
(b)
Impairment and restructuring charges consist of (i) impairment and restructuring charges that are included in our unaudited consolidated statements of operations plus (ii) additional charges relating to inventory and/or manufacturing of our products that are included in cost of sales in the accompanying unaudited consolidated statements of operations of $23 and $1 for the three and six months ended July 1, 2017, respectively. For further explanation of impairment and restructuring charges that are included in our unaudited consolidated statements of operations, see Note 18 - Impairment and Restructuring Charges in our unaudited financial statements.
(c)
Other non-cash items include charges of $12,191 for inventory adjustments related to the ABS acquisition inventory fair valuation in the three and six months ended June 30, 2018.
(d)
Other items not core to business activity include: (i) in the three months ended June 30, 2018, (1) $10,734 in legal costs, and (2) $1,614 in acquisition costs; (ii) in the three months ended July 1, 2017, (1) $7,766 in legal costs, (2) $1,026 in secondary offering costs, and (3) $665 in legal entity consolidation costs; (iii) in the six months ended June 30, 2018 (1) $24,294 in legal costs, (2) $4,164 in acquisition costs, and (3) $2,401 in costs related to the exit of the former CEO ; and (iv) in the six months ended July 1, 2017 (1) $15,762 in legal costs, (2) $1,026 in secondary offering costs, (3) $811 in legal entity consolidation costs, (4) $643 in facility shut down costs, (5) $348 in IPO costs, partially offset by (6) $(2,247) gain on settlement of contract escrow.
(e)
Includes non-recurring fees and expenses related to professional advisors, financial advisors and financial monitors retained in connection with the refinancing of our debt obligations.